Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk

By sjmartinez • September 28, 2023

Tobias DK, Manning AK, Wessel J, Raghavan S, Westerman KE, Bick AG, Dicorpo D, Whitsel EA, Collins J, Correa A, Cupples LA, Dupuis J, Goodarzi MO, Guo X, Howard B, Lange LA, Liu S, Raffield LM, Reiner AP, Rich SS, Taylor KD, Tinker L, Wilson JG, Wu P, Carson AP, Vasan RS, Fornage M, Psaty BM, Kooperberg C, Rotter JI, Meigs J, Manson JE; TOPMed Diabetes Working Group; National Heart, Lung, and Blood Institute TOPMed Consortium. Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk. Diabetes Care. 2023 Sep 27:dc230805. doi: 10.2337/dc23-0805. Epub ahead of print. PMID: 37756531.

Tags: Cedars Sinai DoM, Endocrinology, Publications

Understanding the Link Between Patient Symptoms and Provider Goals for Mucosal Healing in IBD: Insights from the IBD Qorus Survey

Troia A, Harvey S, Wu A, Kiparizoska S, Weaver A, Oberai R, Melmed GY, Siegel CA, Singh S, Mattar MC. Understanding the Link Between Patient[...]

Artificial intelligence prediction of age from echocardiography as a marker for cardiovascular disease

Rawlani M, Ieki H, Binder C, Yuan V, Chiu IM, Bhatt A, Ebinger JE, Sahashi Y, Ambrosy AP, Usuku H, Tsujita K, Cheng P, Kwan[...]

Disease modifying biomaterials for modulating mechanical allodynia in a preclinical model of rheumatoid arthritis

Dolmat M, Lemes JBP, Johnson WT, Wilkinson EL, Yaksh TL, Bottini N, Shah NJ. Disease modifying biomaterials for modulating mechanical allodynia in a preclinical model[...]